In a pilot study patients were randomly allocated to autograft (eight) or non-autograft (seven) groups. The autograft group were given an intradermal injection of a suspension of irradiated autologous tumour-cells mixed with intradermal BCG on the day of operation. Tests of cell-mediated immunity were repeated two weeks after operation. Five patients in each group received a course of radiotherapy to the mediastinum three weeks after operation.
In a pilot study patients were randomly allocated to autograft (eight) or non-autograft (seven) groups. The autograft group were given an intradermal injection of a suspension of irradiated autologous tumour-cells mixed with intradermal BCG on the day of operation. Tests of cell-mediated immunity were repeated two weeks after operation. Five patients in each group received a course of radiotherapy to the mediastinum three weeks after operation.
There was a rise in cutaneous tuberculin reactivity (P=0O08) and total leucocyte count (p = 0O09) in the autograft group postoperatively with a fall in total lymphocyte and T lymphocyte counts in the non-autograft group (P<O0O5). These differences, however, were not followed by any difference in the frequency of tumour recurrence or the survival rate two years after operation.
The results show that the immunological surveillance mechanism is impaired even in patients with early bronchial carcinoma and that it is possible to overcome postoperative immunological depression with specific immunotherapy combined with BCG. This treatment did not produce any clinical advantage in this small number of patients and the skin lesions caused the patients considerable discomfort.
Early reports have suggested that most forms of immunotherapy have at best a weak action against bronchial carcinoma. Immunotherapy is thus likely to be effective only when the tumour cell population has been substantially reduced by surgery or radiotherapy (Price Evans, 1976 Immunotherapy is unlikely to be effective unless immunological function is already depressed. Depression of cell-mediated immunity has been reported in patients with resectable bronchial carcinoma (Dellon et al, 1975; Coy et al, 1977) and after surgical operations (Park et al, 1971 (1973) . The average cell count of the suspension was 14-3X 106/ml, the volume of the suspension being about 20 ml. This was irradiated using a single minimum dose of 12 250 rads (H V L 2 5 mmCu). Provided that a frozen section of the tumour mass confirmed that it was bronchial carcinoma, 3 
Skin tests
A standard tuberculin test using 10 tuberculin units PPD (Weybridge) was performed in 52 patients before operation. This was considered to be positive if the maximum diameter of the induration exceeded 10 mm after 48 hours. Thirtyseven patients were sensitised with 2% DNCB. After more than 10 days a strip consisting of five patches impregnated with serial dilutions of DNCB from 62 5 to 1000 ,ug/ml was applied to the volar surface of the other forearm. The strip was removed two days later and the reaction graded according to the extent of erythema and oedema produced. Erythema covering the area of the disc treated with 500 ,ug/ml was taken as a positive reaction.
Laboratory tests A 40 ml venous blood sample was taken for estimation of total white cell count, total lymphocyte count, T and B cell numbers, and estimation of lymphocyte transformation by phytohaemagglutinin (PHA), pokeweed, and PPD. Of the heparinised whole blood, 20 ml was separated on FicollTriosil mixture to provide lymphocytes for the estimation of T and B cells by the rosetting technique and for the lymphocyte transformation studies (Mackie et al, 1976 nificantly in the autograft group who received 0 5 ml of intradermal BCG in addition to the irradiated tumour cells. In two patients with negative preoperative tuberculin tests postoperative conversion occurred in the one autograft patient but not in the one control patient. In the autograft group there was also a rise in total white cell count, while the total lymphocyte count remained steady. In contrast there was no significant change in tuberculin reactivity or total leucocyte count in the control group but in this group the total lymphocyte count and the T lymphocyte count fell. There was no significant change in the lymphocyte transformation ratios for PHA and pokeweed in either group. Lymphocyte transfor- mation by PPD was not measured in the pilot study, and the number of patients who completed radiotherapy was too small to allow conclusions to be drawn from subsequent immunological tests.
Discussion
In several reports of immunotherapy in resectable bronchial carcinoma the clinical results have been encouraging, but there has been little or no evidence that the treatment has produced any immunological response (Study Group for Bronchogenic Carcinoma, 1975; McKneally et al, 1976) . A possible reason for this is the wide variation and technical difficulty of laboratory tests available.
We have tried to overcome this by using a wide range of tests. A second problem is that cellmediated immunity decreases with age and intercurrent illness (Barnes et al, 1975) , and we have allowed for this by using age-and sex-matched controls for the skin tests and controls over the age of 40 for the laboratory tests.
There was a similar frequency of positive tuberculin tests in patients with resectable bronchial carcinoma and in age-and sex-matched controls from the same area. Sensitisation to DNCB, however, was much less frequent in the carcinoma patients. These two findings have been taken to indicate impairment of the surveillance component of the immunological response (Holmes and Golub, 1976) .
Results of preoperative lymphocyte transformation by PPD have not been previously reported, although Gross and Eddie-Quartey (1976) found lower mean values in 14 patients with bronchial carcinoma, of whom nine had been treated with radiotherapy. Our finding of depressed lymphocyte transformation by PPD with normal cutaneous tuberculin reactivity suggests that the former test is the more sensitive index of tuberculin reactivity.
Tuberculin reactivity increased two weeks after resection of bronchial carcinoma followed by injection of irradiated autologous cells and BCG. Thus intradermal BCG overcame the normal postoperative depression of tuberculin reactivity (Bancewicz et al, 1973) . In contrast the postoperative depression of lymphocyte transformation by PHA observed by Park et al (1971) was not found in either group. In that study, however, depression did not persist for more than one week, whereas the first postoperative measurement in our study was made after two weeks.
The number of patients in this pilot study was too small to allow confident conclusions about the therapeutic effect of specific immunotherapy in bronchial carcinoma, but at the present stage it has not produced any improvement in survival or delay in tumour recurrence. Edwards and Whitwell (1978) using BCG alone in a single subdermal injection of 5X 106 units also failed to increase the survival of patients with resectable tumours. In contrast, McKneally et al (1976) found a significant reduction in the incidence of tumour recurrence among patients treated with intrapleural BCG. In the only trial of irradiated tumour cell injections in bronchial carcinoma so far reported the numbers in the operable group were too small to allow a definite conclusion of its effectiveness to be reached (Oldham et al, 1976 
